Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: Characterization and interaction with human lung fibroblasts

Journal of Controlled Release

Volumn 147, Issue 1, 2010, Pages 127-135

  Marianecci, Carlotta ^a   Paolino, Donatella ^b   Celia, Christian ^b   Fresta, Massimo ^b   Carafa, Maria ^a   Alhaique, Franco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Anti inflammatory activity; Beclomethasone dipropionate; Carrier cell interaction; Non ionic surfactant vesicles; Primary human lung fibroblasts; Pulmonary drug carrier

Indexed keywords

BIOLOGICAL ORGANS; CELL CULTURE; DIGITAL STORAGE; DRUG INTERACTIONS; FIBROBLASTS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; HORMONES; LIGHT SCATTERING; PULMONARY DISEASES; RESPIRATORY SYSTEM; SOLS; SURFACE ACTIVE AGENTS; TARGETED DRUG DELIVERY;

ANTI-INFLAMMATORY ACTIVITY; BECLOMETHASONE DIPROPIONATE; CELL INTERACTION; HUMAN LUNG FIBROBLASTS; PULMONARY DRUG;

CONTROLLED DRUG DELIVERY;

BECLOMETASONE DIPROPIONATE; CYTOTOXIC AGENT; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1BETA; NIOSOME;

ANISOTROPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DEATH; CELL INTERACTION; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STORAGE; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROBLAST; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 85102153146     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.06.022     Document Type: Article

References (37)

1. Karathanasis E., Ayyagari A.L., Bhavane R., Bellamkonda R.V., Annapragada V. Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J. Control. Release 2005, 103:159-175.
2. Carafa M., Di Marzio L., Marianecci C., Cinque B., Lucania G., Kajiwara K., Cifone M.G., Santucci E. Designing novel pH-sensitive non-phospholipid vesicles: characterization and cell interaction. Eur. J. Pharm. Sci. 2006, 28:385-393.
3. Terzano C., Allegra L., Alhaique F., Marianecci C., Carafa M. Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur. J. Pharm. Biopharm. 2005, 59:57-62.
4. Desai T.R., Finlay W.H. Nebulization of niosomal all-trans retinoic acid:an inexpensive alternative to conventional liposomes. Int. J. Pharm. 2002, 241:311-317.
5. Carafa M., Santucci E., Lucania G. Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int. J. Pharm. 2000, 231:221-232.
6. Carafa M., Marianecci C., Lucania G., Marchei E., Santucci E. New vesicular ampicillin-loaded delivery systems for topical application: characterization, in vitro permeation experiments and antimicrobial activity. J. Control. Release 2004, 95:67-74.
7. Paolino D., Muzzalupo R., Ricciardi A., Celia C., Picci N., Fresta M. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery. Biomed. Microdevices 2007, 9:421-433.
8. Paolino D., Cosco D., Muzzalupo R., Trapasso E., Picci N., Fresta M. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int. J. Pharm. 2008, 353:233-242.
9. Cosco D., Paolino D., Muzzalupo R., Celia C., Citraro R., Caponio D., Picci N., Fresta M. Novel PEG-coated Niosomes Based on Bola-surfactant as Drug Carriers for 5-Fluorouracil. Biomed. Microdevices 2009, 11:1115-1125.
10. Attia I.A., El-Gizawy S.A., Fouda M.A., Donia A.M. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS PharmSciTech 2007, 8:E106-E112.
11. Alam M., Dwivedi V., Khan A.A., Mohammad O. Efficacy of niosomal formulation of diallyl sulfide against experimental candidiasis in Swiss albino mice. Nanomedicine 2009, 4:713-724.
12. Jadon P.S., Gajbhiye V., Jadon R.S., Gajbhiye K.R., Ganesh N. Enhanced oral bioavailability of griseofulvin via niosomes. AAPS PharmSciTech 2009, 10:1186-1192.
13. Thakur R., Anwer M.K., Shams M.S., Ali A., Khar R.K., Shakeel F., Taha E.I. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation. J. Drug Target. 2009, 17:442-449.
14. Jain C.P., Vyas S.P. Preparation and characterization of niosomes containing rifampicin for lung targeting. J. Microencapsul. 1995, 12:401-407.
15. Frankenberger M., Häussinger K., Ziegler-Heitbrock L. Liposomal methylprednisolone differentially regulates the expression of TNF and IL-10 in human alveolar macrophages. Int. Immunopharmacol. 2005, 5:289-299.
16. Umland S.P., Schleimer R.P., Johnston S.L. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm. Pharmacol. Ther. 2002, 15:35-50.
17. Oakley R.H., Jewell C.M., Yudt M.R., Bofetiado D.M., Cidlowski J.A. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J. Biol. Chem. 1999, 274:27857-27866.
18. Hochhaus G. New developments in corticosteroids. Proc. Am. Thorac. Soc. 2004, 1:269-274.
19. Santucci E., Carafa M., Coviello T., Murtas E., Riccieri F.M., Alhaique F., Modesti A., Modica A. Vesicles from polysorbate 20 and cholesterol. A simple preparation and characterization. STP Pharma. Sci. 1996, 6:29-32.
20. Carafa M., Santucci E., Alhaique F., Coviello T., Murtas E., Riccieri F.M., Lucania G., Torrisi M.R. Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles. Int. J. Pharm. 1998, 160:51-59.
21. Kato H., Nagai Y., Yamamoto K., Sakabe Y. Determination of polysorbates in foods by colorimetry with confirmation by infrared spectrophotometry, thin-layer chromatography, and gas chromatography. J. Assoc. Off. Anal. Chem. 1989, 72:27-29.
22. Celia C., Trapasso E., Cosco D., Paolino D., Fresta M. Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf. B Biointerfaces 2009, 72:155-160.
23. Shinitzky M., Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim. Biophys. Acta 1978, 515:367-394.
24. Vancheri C., Sortino M.A., Tomaselli V., Mastruzzo C., Condorelli F., Bellistri G., Pistorio M.P., Canonico P.L., Crimi N. Different expression of TNF-areceptors and prostaglandin E2 production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process. Am. J. Respir. Cell Mol. Biol. 2000, 22:628-634.
25. Darwis Y., Kellaway I.W. Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes. Int. J. Pharm. 2001, 215:113-121.
26. Elhissi A.M., O'Neill M.A., Roberts S.A., Taylor K.M. A calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid-liposome interactions for liposomes prepared by thin film and proliposome methods. Int. J. Pharm. 2006, 320:124-130.
27. Lenz R.R. Membrane fluidity as detected by diphenylhexatriene probes. Chem. Phys. Lipids 1989, 50:171-190.
28. Saettone M.F., Perini G., Carafa M., Santucci E., Alhaique F. Non-ionic surfactant vesicle as ophthalmic carriers for cyclopentolate. A preliminary evaluation. STP Pharma Sci. 1996, 6:94-98.
29. Arunothayanun P., Bernard M.S., Craig D.Q., Uchegbu I.F., Florence A.T. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int. J. Pharm. 2000, 201:7-14.
30. Dimitrijevic D., Shaw A.J., Florence A.T. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells. J. Pharm. Pharmacol. 2000, 52:157-162.
31. Dias N., Mortara R.A., Lima N. Morphological and physiological changes in Tetrahymena pyriformis for the in vitro cytotoxicity assessment of Triton X-100. Toxicol. In Vitro 2003, 17:357-366.
32. Hirama S., Tatsuishi T., Iwase K., Nakao H., Umebayashi C., Nishizaki Y., Kobayashi M., Ishida S., Okano Y., Oyama Y. Flow-cytometric analysis on adverse effects of polysorbate 80 in rat thymocytes. Toxicology 2004, 199:137-143.
33. Lin H., Gebhardt M., Bian S., Kwon K.A., Shim C.K., Chung S.J., Kim D.D. Enhancing effect of surfactants on fexofenadine HCl transport across the human nasal epithelial cell monolayer. Int. J. Pharm. 2007, 330:23-31.
34. Di Marzio L., Marianecci C., Cinque B., Nazzarri M., Cimini A.M., Cristiano L., Cifone M.G., Alhaique F., Carafa M. pH-sensitive non-phospholipid vesicle and macrophage-like cells: binding, uptake and endocytotic pathway. Biochim. Biophys. Acta 2008, 1778:2749-2756.
35. Braun A., Appel E., Baruch R., Herz U., Botchkarev V., Paus R., Brodie C., Renz H. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur. J. Immunol. 1998, 28:3240-3251.
36. de Vries A., Dessing M.C., Engels F., Henricks P.A.J., Nijkamp F.P. Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs. Am. J. Respir. Crit. Care Med. 1999, 159:1541-1544.
37. Olgart C., Frossard N. Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids. Eur. Respir. J. 2001, 18:115-121.